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Abstract
A simple and straightforward synthetic approach to potential anti-infective thiolactone-isatin hybrids led to the discovery of novel
tetracyclic compounds which bear a macrocylic motif containing an unusual bridged amide bond.
Introduction
Hybrid structures have been found in nature and their synthesis
has become a useful drug discovery strategy for new anti-
infective agents [1]. Improved pharmacokinetics, therapeutic
and toxicity profiles have been reported for natural and natural
product-like hybrid constructs such as the artemisinin-quinine
[2], nostocarboline-ciprofloxacin [3] and isatin-lamuvidine [4]
(Figure 1). Interest in exploring this approach also derives from
the pharmacophore-rich compound library it offers. This
precludes the need for large libraries and concomitantly
shortens the time needed to identify potential leads [5]. The
focus of this study is on the synthesis of hybrids with monomers
derived from natural products thiolactomycin (1) and isatin (2)
(Figure 2). The former is a thiolactone antibiotic known for its
remarkable selectivity against the condensing enzymes of type
II fatty acid synthesis which operate in a number of pathogenic
organisms [6-8]. Synthetic methodologies for 1 and a series of
racemic and enantiopure thiolactomycin-based analogues have
been reported [9-16]. Of particular interest to this project are the
structure-activity relationships delineated from O-4 modified
analogues which reportedly display enhanced antimalarial and
promising antitubercular activity [15,16]. The other component
of the envisaged hybrid, isatin (2) is an intriguing and syntheti-
cally versatile scaffold. Moreover, its presence in a number of
proprietary molecules and synthetic drugs is noteworthy [17].
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Figure 1: Natural product and natural product-like hybrids.
Figure 2: Structures of thiolactomycin (1), isatin (2), the desired hybrid
3 and tetracycle 4.
Alkylation of 5, as shown in Scheme 1, is a common route
towards diverse thiolactomycin analogues. A literature review
revealed that γ-thiolactones are prone to undergo ring-opening
polymerization under the basic conditions required to effect
alkylation [18] and this has been cited as a likely contributor to
the low yields reported in thiolactomycin analogue synthesis.
For example, Takabe and co-workers [19] attempted O-alkyl-
ation of 5 using NaH and CH3I at room temperature. Although
the reaction proceeded regioselectively, only 9% of the desired
C-4 O-alkylated product was obtained after a reaction time of
144 h.
We herein report the synthesis of a novel series of thiolactone-
isatin hybrids. The envisaged target compounds 3, as shown in
Figure 2, are modeled on 1 but devoid of the hydrophobic side
chain represented by the isoprenoid moiety at C-5.
Results and Discussion
The key intermediate, thiolactone 5 (Scheme 1), was syn-
thesized using a four-step reaction developed by Wang and
Salvino [20]. The N-alkylated 5-substituted isatin/isatin inter-
mediates 6 were obtained in a one-step reaction in good to
excellent yields by the reported procedure [21]. Thus, with 5
and 6 in hand, synthesis of the desired hybrids 3 was
subsequently undertaken.
For our synthesis we explored the use of bases of varying
strengths, starting with NaH. Although NaH afforded the
desired hybrids 3 and traces of the tetracycle 4, the obtained
yields were very poor. Next, the use of the weaker base,
K2CO3, was attempted. Refluxing 5 and 6 in acetone in the
presence of 4 equiv of K2CO3 did not produce 3. Instead, an
unidentified product was isolated from the product mixture,
whose 1H and 13C NMR suggested that it is possibly an aldol
product. All efforts were then directed towards a method which
utilizes the potassium salt of 5. The salt was obtained in quanti-
tative yield from the reaction of 5 with an equimolar amount of
aqueous potassium hydroxide in MeOH at room temperature.
Although no reaction between the potassium salt of 5 and 1.5
equiv of 6 in anhydrous DMF was observed at room tempera-
ture, when the temperature was increased to 60 °C, TLC
confirmed the consumption of the starting material after stir-
ring at this temperature for 48 h (see Supporting Information
File 1 for full experimental data). The difficulties in purifica-
tion of the crude reaction mixtures may have contributed unfa-
vourably towards the yields obtained for hybrids 3 (Table 1).
These yields, although disappointingly low, are in agreement
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Scheme 1: Reagents and conditions: (a) KOH, MeOH, 25 °C, 95–100% (b) 6, DMF, 60 °C, 9–36%.
with published reports on thiolactomycin analogues synthesis
[15,18,20,22,23]. Of particular interest, however, was the
formation of by-products (tetracycles) observed in the reaction
of 5 with the N-alkylated isatin intermediates 6 bearing the
n = 3–5 linkers (Table 1). The tetracycle 4 had a slightly lower
Rf than the desired hybrid 3 and was colorless or light yellow
compared to the orange-colored hybrid 3. We initially suspected
it to be a regioisomer of 3, that is, the C-3-alkylated or C-2
O-alkylated product consistent with the resonance contributors
of the anion of 5. Lack of regioselectivity in the alkylation reac-
tions of thiolactomycin and its analogues is a common synthetic
problem [22-24].
Table 1: Synthesis of thiolactone-isatin hybrids 3 and tetracycles 4.
Compd R n (3:4)a Yield (%)
3a Br 1 100:0 9
3b Cl 1 100:0 13
3c F 1 100:0 14
3d I 1 100:0 10
3e CH3 1 100:0 26
3f H 1 100:0 36
3g H 2 100:0 18
3h, 4a H 3 22:78 45b
3i, 4b H 4 84:16 31b
3j, 4c H 5 71:29 21b
aDetermined from isolated yields;
bCombined isolated yields of 3 and 4.
Interest in the tetracycles 4 was further sparked by the ease and
simplicity of their preparation, and the novelty of their architec-
ture as revealed by single X-ray crystal structure analysis.
Attractive structural features of 4 include two vicinal quaternary
stereocenters and a complex, bicyclic ring system containing a
bridged amide bond. Essentially, the amide functionality adopts
a planar conformation in normal amides with stability being
conferred by the delocalization of the nitrogen lone pair into the
C=O bond [25]. The amides in bicyclic bridgehead lactams are
distorted from planarity and this severely affects their reactivity
and stability [26-31]. Furthermore, the use of bridged amides as
scaffolds in medicinal chemistry has been explored [32-37].
Indeed, the enhanced electrophilicity or acylating ability of
β-lactams is partially attributed to the distortion from planarity
of the amide bond [28,38]. Also present in the structure of the
tetracycles 4 is the 3-substituted 3-hydroxyindolin-2-one moiety
which features prominently in a number of biologically active
natural products [39-41].
The mechanism proposed for the formation of 4 as outlined in
Scheme 2, involves an in situ deprotonation at C-5 of the
thiolactone ring system by the relatively basic potassium salt of
5. This is followed by the regioselective, intramolecular addi-
tion of the nucleophile to the ketonic carbonyl facilitated by (i)
the strong electrophilicity of the α-keto amide group of the
isatin scaffold, (ii) the flexible alkane tether (n = 3–5) which
allows for the proper alignment of the orbitals of the reacting
groups and (iii) the rigidity [42] of the isatin and thiolactone
ring systems. In the absence of supporting information we spec-
ulate that the observed regioselectivity may be due to the ther-
modynamically more stable product 4α arising from reaction at
the α-position due to a more extended conjugated system
relative to the product 4γ (Scheme 2) that would result from
reaction at the γ-position. Scheme 2 also indicates that only one
diastereomer of tetracycle 4 is formed as indicated by X-ray
crystallographic data. The absence of the other diastereomer
may be due to destabilizing steric interactions with the carbonyl
group of the amide and the oxygen of the vinyl ether. Similar
cyclizations leading to bridged lactams have been reported
[43,44].
Beilstein J. Org. Chem. 2010, 6, No. 78.
Page 4 of
(page number not for citation purposes)
7
Scheme 2: Proposed mechanism for the formation of tetracycles 4.
Synthesis of tetracycles 4 was therefore expanded to obtain a
small library for biological testing. Although a model study
revealed that prolonged reaction times (120 h) resulted in an
increase in tetracycle 4 formation, we were unable to signifi-
cantly increase the yields of the bridged products despite much
longer reaction times (Table 2).
It is noteworthy that 4 did not form with the n = 1–2 linked
hybrids 3a–g (Table 1). This is most likely due to strain in the
transition state. Also notable is the decrease in yield with
increasing linker length as evidenced by the differences
observed for the n = 3–5 linked tetracycles/5′-substituted tetra-
cycles (Table 1 and Table 2). This drawback can most likely be
ascribed to entropy factors and stereoelectronic effects [45-48].
The structures of the tetracycles 4 were unambiguously
assigned by single crystal X-ray crystallographic analysis.
Single crystals for 4a–c were obtained from MeOH at room
temperature and subjected to crystallographic analysis (see
Supporting Information File 2 for crystallographic data).
Figure 3 shows the molecular structure and atom labeling for
4a. The crystals are triclinic with space group P−1 and contains
four molecules per unit cell. The crystal structure furthermore
Table 2: Synthesis of thiolactone-isatin hybrids 3 and tetracycles 4.
Compd R n (3:4)a Yield (%)c
4d Br 3 11:89 14
4e I 3 10:90 15
4f F 3 19:81 10
4g Cl 3 15:85 14
4h NO2 3 30:70 8
4i Cl 4 63:37b 5
4j Br 4 67:33b 7
4k I 4 60:40b 4
4l Cl 5 80:20 6
4m F 5 69:31 7
4n Br 5 73:27 6
4o I 5 70:30 7
aDetermined from isolated yields;
bRatio determined from crude reaction mixture using 1H NMR;
cIsolated yields of 4.
revealed the presence of two crystallographic independent
molecules in the unit cell differentiated with the labels A and B
in the atom numbering scheme (Figure 3b). Because of similar
trends observed in the bond angles and lengths, we have limited
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Figure 3: (a) Molecular structure of the tetracycle 4a. (b) Structure of the dimer of 4a showing the atomic numbering scheme. Displacement ellipsoids
are drawn at 40% probability level for non-hydrogen atoms. All hydrogen atoms are omitted except the hydroxyl hydrogens.
Figure 4: Molecular structure of (a) 4b and (b) 4c, with ellipsoidal model of probability level = 35%.
our discussion to molecule A. In this structure (Figure 3b) the
indole ring is almost planar with C7A and C8A showing devi-
ations of −0.0918(10) and +0.0902(11), respectively from the
least square plane. The syn relationship between the methyl at
C5A and the hydroxyl group at C7A was evident from the
torsion angle of −65.81° (14) for O4A-C7A-C5A-C6A. Also
noted are the dihedral angles 106.80° (11) and 113.29° (11) for
O4A-C7A-C5A and C6A-C5A-C7A, respectively, which shows
a distortion from the ideal value (109.47°) for a tetrahedral sp3
carbon. Speculatively, this distortion coupled with the elon-
gated C7A-C5A [1.5783(19) Å] bond indicates a repulsive
steric interaction between the relatively bulky hydroxyl group at
C7A and the adjacent methyl group at C5A.
Figure 4 shows the molecular structure atom labeling for 4b–c.
Both compounds crystallized in the centrosymmetric mono-
clinic space group P21/n with 4 molecules in the unit cell.
Similar to 4a, the indole moiety is nearly planar with the
maximum deviation from the least-squares plane for all the nine
atoms in the ring at +0.045(1) and +0.0412(15) for C8, in 4b
and 4c, respectively.
In recognition of the potential contribution of distorted bridged
amides to biological activity as alluded to earlier, the calcula-
tion of the Dunitz–Winkler distortion parameters (τ, χC, χN)
[25,49,50] for the tetracycles 4a–c was undertaken (Table 3).
Compared to planar formamide whose distortion parameters are
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all 0° [53] compound 4a with a twist angle τ of 10.4° (Table 3),
show a slight distortion from planarity, whereas the amide dis-
tortion parameters for 4b–c indicate that the amide bond is close
to being planar. It is also known that twisted amides contain
pyramidal nitrogen atoms, which makes it a potential site for
reaction with protons and electrophiles [25,31]. However, for
4a–c the carbon and nitrogen pyramidality (χC and χN) and the
N-C(=O) and C=O bond lengths (Table 3) all indicate that the
bridge amide bond is essentially relaxed.
Table 3: Calculated Dunitz-Winkler distortion parameters and amide
bond lengths of planar formamide and 4a–c.
Parametera Formamide(planar)b 4a
c 4b 4c
τ/° 0.0 10.4 5.3 0.6
χC/° 0.0 0.7 3.0 4.5












In summary we have described the straightforward synthesis of
novel compounds 3 and 4. The latter bears quaternary stereo-
genic centers and a macrocylic motif containing an unusual
bridged amide bond. The poor yields obtained are a concern and
require further optimization of reaction conditions. A study of
the biological activity of the novel structures (3 and 4) is
currently underway.
Supporting Information
Supporting information contains full experimental and
spectral data for thiolactone 5, the desired hybrids 3,
tetracycles 4 and the general procedure for the synthesis of
the N-alkylated 5-substituted isatin/isatin intermediates 6.
The 1H NMR and 13C NMR spectra for compounds 3 and 4
are also included.
Supporting Information File 1
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